Diabetes complications

A simple and accessible diabetic retinopathy risk prediction model: Establishment and validation in a hospital-based cohort of type 2 diabetes patients

Diabetes Res Clin PractPublished Retrospective cohort study

Authors' conclusion

The proposed model shows promise for guiding early interventions and improving outcomes. Further external validation is needed to confirm its applicability across diverse populations.

Study context

Population
Patients with T2D admitted 2013–2019 (70,073 screened); mean age 59 yearsof 70,073 screened
Participants
2,585 patients
Exposure
Derivation vs Validation
Outcome
Diabetic retinopathy (DR) prediction (retinopathy-free survival) by nomogram: discrimination and calibration
Follow-up
1, 3 and 5 years
Methodological detailshospital-based, prediction model development and validation, random derivation (2/3) and validation (1/3) sets, Cox proportional hazards regression, nomogram
  • Hospital-based
  • Prediction model development and validation
  • Random derivation (2/3) and validation (1/3) sets
  • Cox proportional hazards regression
  • Nomogram

Main finding

As reported in the abstract

Discrimination (AUC) of nomogram for 1-, 3-, 5-year retinopathy-free survival
GroupAUC 1-yearAUC 3-yearAUC 5-year
Derivation0.9410.8860.594
Validation0.7470.7360.670

AUC 1-year

Derivation0.941
Validation0.747

AUC 3-year

Derivation0.886
Validation0.736

AUC 5-year

Derivation0.594
Validation0.670

Observational data: associations, not effects.

Further findings

Incident retinopathy · median follow-up 34 months

Developed retinopathy
220 (8.5 %)

Original publication

A simple and accessible diabetic retinopathy risk prediction model: Establishment and validation in a hospital-based cohort of type 2 diabetes patients. Diabetes Res Clin Pract. Published 2 May 2025. doi:10.1016/j.diabres.2025.112211

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.